Family communication and the efficacy of family focused therapy in individuals at clinical high risk for psychosis with comorbid anxiety.

anxiety clinical high risk for psychosis enhanced care family focused treatment family problem-solving interaction task

Journal

Early intervention in psychiatry
ISSN: 1751-7893
Titre abrégé: Early Interv Psychiatry
Pays: Australia
ID NLM: 101320027

Informations de publication

Date de publication:
03 2023
Historique:
revised: 31 03 2022
received: 20 08 2021
accepted: 29 05 2022
pubmed: 21 6 2022
medline: 22 3 2023
entrez: 20 6 2022
Statut: ppublish

Résumé

Comorbid anxiety disorder is related to greater illness severity among individuals at clinical high risk (CHR) for psychosis, but its potential role in moderating response to Family Focused Therapy (FFT) for CHR is unexamined. We investigated whether comorbid anxiety disorder in CHR individuals is associated with less constructive communication during family problem-solving interactions, whether their communication skills differentially improve after FFT, and whether FFT is effective in reducing anxiety in this population. Individuals recruited into the second phase of the 8-site North American Prodrome Longitudinal Study (NAPLS2) participated (N = 129). They were randomly assigned to 18-sessions of FFT-CHR or three-sessions of Enhanced Care (EC). Participants completed a diagnostic interview at pre-treatment, a family interaction task at pre-treatment and 6-months, and a self-report anxiety measure at pretreatment, 6 and 12-months. Individuals at CHR with comorbid anxiety engaged in more negative and fewer positive behaviours during family problem-solving interactions at pre-treatment than did those without comorbid anxiety. There was a significant interaction between anxiety diagnosis and time on interactional behaviour scores, such that individuals at CHR with an anxiety diagnosis showed a greater decrease in negative behaviours and increase in positive behaviours from baseline to 6-months than those without anxiety disorder(s) regardless of treatment condition. However, individuals' self-reported anxiety symptoms decreased more in FFT-CHR than in EC from pre-treatment to 12-month follow-up, regardless of anxiety diagnoses. Individuals at CHR with symptoms of anxiety benefit from family interventions in showing reductions in anxiety and improvements in family communication.

Identifiants

pubmed: 35719024
doi: 10.1111/eip.13326
pmc: PMC10228682
mid: NIHMS1899521
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

281-289

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH123575
Pays : United States
Organisme : NIH HHS
ID : MH088546
Pays : United States

Informations de copyright

© 2022 John Wiley & Sons Australia, Ltd.

Références

J Am Acad Child Adolesc Psychiatry. 2014 Aug;53(8):848-58
pubmed: 25062592
J Affect Disord. 2021 May 1;286:282-295
pubmed: 33756306
J Consult Clin Psychol. 2008 Apr;76(2):282-97
pubmed: 18377124
Dev Psychopathol. 2021 Feb;33(1):226-239
pubmed: 32096757
Schizophr Res. 2006 Jan 31;81(2-3):269-75
pubmed: 16309893
Schizophr Bull. 2014 Jan;40(1):120-31
pubmed: 23180756
Am J Psychiatry. 2015 Mar 1;172(3):249-58
pubmed: 25727537
Psychosomatics. 1971 Nov-Dec;12(6):371-9
pubmed: 5172928
Schizophr Res. 2009 Feb;107(2-3):198-205
pubmed: 18996681
J Clin Child Adolesc Psychol. 2010;39(3):410-20
pubmed: 20419581
Psychol Rep. 1977 Feb;40(1):303-6
pubmed: 840986
Lancet. 2011 Jun 18;377(9783):2093-102
pubmed: 21652063
NPJ Schizophr. 2020 Oct 5;6(1):27
pubmed: 33020486
Dev Psychol. 2020 Mar;56(3):390-402
pubmed: 32077712
J Affect Disord. 2016 Oct;203:101-110
pubmed: 27285723
Clin Child Fam Psychol Rev. 2022 Mar;25(1):110-129
pubmed: 35195833
J Am Acad Child Adolesc Psychiatry. 2001 Oct;40(10):1182-9
pubmed: 11589531
Clin Psychol Rev. 2006 Nov;26(7):834-56
pubmed: 16473441
Early Interv Psychiatry. 2017 Dec;11(6):480-487
pubmed: 26456932
J Consult Clin Psychol. 2003 Jun;71(3):482-92
pubmed: 12795572
J Consult Clin Psychol. 1996 Apr;64(2):333-42
pubmed: 8871418
Psychol Bull. 1979 Mar;86(2):420-8
pubmed: 18839484
J Consult Clin Psychol. 2014 Feb;82(1):90-101
pubmed: 24188511
J Fam Psychol. 2015 Dec;29(6):945-51
pubmed: 26168262
Clin Psychol Rev. 1997;17(1):47-67
pubmed: 9125367
Schizophr Res. 2015 Dec;169(1-3):186-192
pubmed: 26526751
Schizophr Bull. 1996;22(2):353-70
pubmed: 8782291
J Clin Child Adolesc Psychol. 2012;41(1):64-74
pubmed: 22233246
J Fam Psychol. 2018 Jun;32(4):507-516
pubmed: 29389150
Schizophr Res. 2012 Dec;142(1-3):77-82
pubmed: 23043872
Early Interv Psychiatry. 2012 Aug;6(3):283-91
pubmed: 22182667

Auteurs

Arianna C O'Brien Cannon (AC)

Department of Psychology, American University, Washington, District of Columbia, USA.

Nicole E Caporino (NE)

Department of Psychology, American University, Washington, District of Columbia, USA.

Mary P O'Brien (MP)

Department of Psychology, Yale University, New Haven, Connecticut, USA.

David J Miklowitz (DJ)

Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Behavior, University of California, California, Los Angeles, USA.

Jean M Addington (JM)

Department of Psychiatry, University of Calgary, Calgary, Canada.

Tyrone D Cannon (TD)

Department of Psychology, Yale University, New Haven, Connecticut, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH